Manufacturer
140 recalls in our database name Sun Pharmaceutical Industries, Inc. as the manufacturing or recalling firm.
Of the 140 recalls from Sun Pharmaceutical Industries, Inc. we have scored against our rubric, 1 (1%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 11 (8%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Sun Pharmaceutical Industries is recalling 1,416 bottles of Atorvastatin Calcium 40 mg tablets because a latex glove was found in one lot.
Sun Pharmaceutical Industries is recalling 624 bottles of Doxycycline Capsules, 75 mg, because they were not manufactured under Current Good Manufacturing Practice conditions.
Sun Pharmaceutical Industries is recalling 207,585 blisters of Sumatriptan Succinate 100 mg tablets due to failed impurity specifications.
Sun Pharmaceutical Industries is recalling Testosterone Cypionate for Injection due to cGMP deviations and similarity to a previously rejected out-of-specification lot.
Sun Pharmaceutical Industries is recalling Testosterone Cypionate for Injection due to cGMP deviations and similarity to a previously rejected lot.
Sun Pharmaceutical Industries is recalling specific lots of Sumatriptan Succinate 50 mg tablets because they failed impurity specifications.
Sun Pharmaceutical is recalling Wal-Fex D allergy and congestion tablets because testing showed impurity levels above or near specification limits.
Sun Pharmaceutical is recalling Allergy Relief D tablets because testing showed impurities above or near specification limits.
Sun Pharmaceutical is recalling Wal-Fex D tablets because testing showed impurity levels above or near specification limits.
Sun Pharmaceutical is recalling Allergy Relief D tablets because testing showed impurities and degradation levels above or near specification limits.
Sun Pharmaceutical is recalling BromSite (bromfenac) 0.075% ophthalmic solution due to a lack of sterility assurance. The recall affects 69,840 bottles distributed nationwide.
Sun Pharmaceutical Industries is recalling 5,040 cartons of Loperamide Hydrochloride 2 mg tablets because the carton front and side panels display conflicting caplet counts.
Sun Pharmaceutical Industries is recalling Vecuronium Bromide for Injection because glass particles were detected in the product.
Sun Pharmaceutical Industries is recalling Vecuronium Bromide for Injection because glass particles were detected in the product.
Sun Pharmaceutical Industries is recalling Absorica LD (Isotretinoin) capsules because the active ingredient content was lower than the required specification limit.
Sun Pharmaceutical Industries is recalling Testosterone Cypionate Injection vials because organic and inorganic particulate matter was detected in the product.
Sun Pharmaceutical Industries is recalling one lot of Metformin Hydrochloride Extended Release Tablets because a piece of rubber glove was detected in a tablet.
Sun Pharmaceutical Industries is recalling one lot of Sulfamethoxazole and Trimethoprim tablets because polyethylene was detected in two tablets.
Sun Pharmaceutical Industries is recalling Riomet (metformin hydrochloride) oral solution due to identified labeling discrepancies in the patient literature.
Sun Pharmaceutical is recalling Azelastine HCl Nasal Solution 0.1% because it failed a droplet size stability test. The recall covers 17,554 bottles distributed nationwide.
Sun Pharmaceutical Industries is recalling 393 vials of Doxorubicin Hydrochloride Liposome Injection due to a lack of assurance of sterility.
Sun Pharmaceutical Industries is recalling Riomet (metformin hydrochloride) oral solution due to microbial contamination. The recall covers specific lots of the cherry-flavored prescription liquid.
Sun Pharmaceutical Industries is recalling 13,200 bottles of Children's Cetirizine Hydrochloride Chewable Tablets due to out-of-specification tablet hardness.
Sun Pharmaceutical Industries is recalling Olanzapine Tablets, 7.5 mg, because they failed impurity specifications. The recall covers 6,138 bottles distributed nationwide and in Puerto Rico.
Sun Pharmaceutical Industries is recalling specific lots of Olanzapine Tablets, 2.5 mg, because they failed impurity specifications.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
Sun Pharmaceutical
Indian multinational pharmaceutical company
Source: Wikidata (Q3291801), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.